Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Role of biomarkers in understanding and treating children with asthma: towards personalized care.

Lang JE, Blake KV.

Pharmgenomics Pers Med. 2013 Aug 21;6:73-84. doi: 10.2147/PGPM.S30626. Review.

2.
3.

Low-grade disease activity in early life precedes childhood asthma and allergy.

Chawes BL.

Dan Med J. 2016 Aug;63(8). pii: B5272. Review.

PMID:
27477800
4.

Inflammatory biomarkers for asthma endotyping and consequent personalized therapy.

Ciprandi G, Tosca MA, Silvestri M, Ricciardolo FLM.

Expert Rev Clin Immunol. 2017 Jul;13(7):715-721. doi: 10.1080/1744666X.2017.1313117. Epub 2017 Apr 11.

PMID:
28347164
5.

Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).

Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P.

Pediatrics. 2001 Aug;108(2):E36.

PMID:
11483846
6.

Omalizumab for asthma in adults and children.

Normansell R, Walker S, Milan SJ, Walters EH, Nair P.

Cochrane Database Syst Rev. 2014 Jan 13;(1):CD003559. doi: 10.1002/14651858.CD003559.pub4. Review.

PMID:
24414989
7.

Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.

Chauhan BF, Ducharme FM.

Cochrane Database Syst Rev. 2012 May 16;(5):CD002314. doi: 10.1002/14651858.CD002314.pub3. Review.

8.

Can biomarkers help us hit targets in difficult-to-treat asthma?

Fricker M, Heaney LG, Upham JW.

Respirology. 2017 Apr;22(3):430-442. doi: 10.1111/resp.13014. Epub 2017 Mar 1. Review.

PMID:
28248008
9.

Exhaled nitric oxide and the management of childhood asthma--yet another promising biomarker "has been" or a misunderstood gem.

Turner S.

Paediatr Respir Rev. 2015 Mar;16(2):88-96. doi: 10.1016/j.prrv.2014.07.005. Epub 2014 Aug 7. Review.

PMID:
25182668
10.

Biomarkers of therapy responsiveness in asthma: pitfalls and promises.

Vijverberg SJ, Koenderman L, Koster ES, van der Ent CK, Raaijmakers JA, Maitland-van der Zee AH.

Clin Exp Allergy. 2011 May;41(5):615-29. doi: 10.1111/j.1365-2222.2011.03694.x. Review.

PMID:
21488995
11.

Childhood asthma biomarkers: present knowledge and future steps.

Moschino L, Zanconato S, Bozzetto S, Baraldi E, Carraro S.

Paediatr Respir Rev. 2015 Sep;16(4):205-12. doi: 10.1016/j.prrv.2015.05.001. Epub 2015 May 12. Review.

PMID:
26100359
12.

Personalized medicine in children with asthma.

Pijnenburg MW, Szefler S.

Paediatr Respir Rev. 2015 Mar;16(2):101-7. doi: 10.1016/j.prrv.2014.10.003. Epub 2014 Nov 8. Review.

PMID:
25458797
13.

Longitudinal study on the relationship between cat allergen and endotoxin exposure, sensitization, cat-specific IgG and development of asthma in childhood--report of the German Multicentre Allergy Study (MAS 90).

Lau S, Illi S, Platts-Mills TA, Riposo D, Nickel R, Grüber C, Niggemann B, Wahn U; Multicentre Allergy Study Group.

Allergy. 2005 Jun;60(6):766-73.

14.

Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma.

Rabinovitch N, Mauger DT, Reisdorph N, Covar R, Malka J, Lemanske RF Jr, Morgan WJ, Guilbert TW, Zeiger RS, Bacharier LB, Szefler SJ.

J Allergy Clin Immunol. 2014 Feb;133(2):350-6. doi: 10.1016/j.jaci.2013.07.039. Epub 2013 Sep 29.

15.

Relationship between exhaled nitric oxide and IgE sensitisation in patients with asthma: influence of steroid treatment.

Syk J, Undén AL, Alving K.

Clin Respir J. 2009 Jul;3(3):143-51. doi: 10.1111/j.1752-699X.2008.00124.x.

PMID:
20298397
16.

Allergen exposure modifies the relation of sensitization to fraction of exhaled nitric oxide levels in children at risk for allergy and asthma.

Sordillo JE, Webb T, Kwan D, Kamel J, Hoffman E, Milton DK, Gold DR.

J Allergy Clin Immunol. 2011 May;127(5):1165-72.e5. doi: 10.1016/j.jaci.2011.01.066. Epub 2011 Apr 3.

17.

Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence.

Gruchalla RS, Sampson HA, Matsui E, David G, Gergen PJ, Calatroni A, Brown M, Liu AH, Bloomberg GR, Chmiel JF, Kumar R, Lamm C, Smartt E, Sorkness CA, Steinbach SF, Stone KD, Szefler SJ, Busse WW.

J Allergy Clin Immunol. 2009 Aug;124(2):213-21, 221.e1. doi: 10.1016/j.jaci.2009.05.036. Epub 2009 Jul 16.

18.

Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.

D'Amato G, Liccardi G, Noschese P, Salzillo A, D'Amato M, Cazzola M.

Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):227-9. Review.

PMID:
15379589
19.

Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab).

D'Amato G, Bucchioni E, Oldani V, Canonica W.

Treat Respir Med. 2006;5(6):393-8.

PMID:
17154668
20.

Supplemental Content

Support Center